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Zareen Amtul1* , Jun Yang2, Ting-Yim Lee2 and David F. Cechetto1
1 Department of Anatomy and Cell Biology, University of Western Ontario, London, ON, Canada, 2 Robarts Research
Institute, University of Western Ontario, London, ON, Canada
Aberrations in brain microcirculation and the associated increase in blood-brain-barrier
(BBB) permeability in addition to neuroinflammation and Aβ deposition observed in
Alzheimer’s disease (AD) and ischemia have gained considerable attention recently.
However, the role of microvascular homeostasis as a pathogenic substrate to disturbed
microperfusion as well as an overlapping etiologic mechanism between AD and ischemia
has not been thoroughly explored. In this study, we employ temporal histopathology
of cerebral vasculature in a rat model of β-amyloid (Aβ) toxicity and endothelin-1
induced-ischemia (ET1) to investigate the panorama of cerebral pathology and the
protein expression on d1, d7, and d28 post-injury. The combination of Aβ and ET1
pathological states leads to an alteration in microvascular anatomy, texture, diameter,
density, and protein expression, in addition to disturbed vessel-matrix-connections,
inter-compartmental water exchange and basement membrane profile within the lesion
epicenter localized in the striatum of Aβ+ET1 brains compared to Aβ and ET1 rats.
We conclude that the neural microvascular network, in addition to the neural tissue,
is not only sensitive to structural deterioration but also serves as an underlying
vascular etiology between ischemia and AD pathologies. Such investigation can provide
prospects to appreciate the interrelationships between structure and responses of
cerebral microvasculature and to provide a venue for vascular remodeling as a new
treatment strategy.
Keywords: beta-amyloid, ischemia, microvessels, basement membrane, vascular anatomy
INTRODUCTION
In general, the microvascular bed of the brain is considered functionally adynamic and less sensitive
to the morphological injuries than the neurons they serve and their supportive cells (del Zoppo
et al., 2000), due to the comparative resistance of brain endothelium to hypoxia, to a certain extent
(Tagaya et al., 1997). However, cerebral microvessels [includes the capillaries and their afferent
Abbreviations: ABC, avidin-biotin complex; AD, Alzheimer’s disease; APP, amyloid precursor protein; AQP4, aquaporin4;
Aβ, β-amyloid; BBB, blood-brain barrier; DAB, 3,3′-diaminobenzidine tetrahydrochloride; ET1, endothelin-1; ICV,
Intracerebroventricular; MMP-9, matrix metalloproteinase9; PBS, phosphate-buffered saline; βDG, β-dystroglycan.
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(arterioles) – efferent (venules) connections] are either the target
or consequence of numerous insults such as focal ischemia (del
Zoppo et al., 2000), cerebral amyloid angiopathy (Ujiie et al.,
2003), vascular dementia (Parnetti et al., 1994), hypertensive
angiopathy (Baumbach and Heistad, 1989), autoimmune
vasculitides, hyperglycemia, and inflammatory disorders
(Paul et al., 2007). Chronic hydrocephalus, in particular,
is associated with reduced cerebral blood flow and direct
compression of fibers, blood vessels or brain tissue [reviewed in
Owler and Pickard (2001)].
Consequential footprints of vascular defects are BBB
breakdown, leakage of blood-borne molecules, swelling of
astrocytic endfeet, interruption of inter-compartmental fluid
exchange, disruption of basement membrane (BM), vessel-
matrix-connections (Bailey et al., 2004), and disturbed capillary
physiology (Paul et al., 2007; Brown and Thore, 2011) that
leads to altered brain microcirculation [reviewed in Amtul
and Hepburn (2014)]. Vascular functional defects have been
described in AD transgenic animal models (Ujiie et al., 2003) and
patients (Farrall and Wardlaw, 2009). For instance, vaccination
against β-amyloid (Aβ); the hallmark of the AD, has been
shown to reverse BBB pathology (Dickstein, 2006). Similarly,
BBB breakdown due to the dissolution of primary endothelial
cell permeability barrier and resulting hypoperfusion is also
an antecedent event to cerebral ischemia (Hawkins, 2005).
Intriguingly, there is a great majority of patients with first-ever
stroke, who developed post-stroke dementia (Pendlebury and
Rothwell, 2009), establishing that ischemic and AD pathogeneses
interact with each other.
In this regard, we have demonstrated some very key
pathological changes in the combined animal model
of Aβ toxicity and ischemia, such as lateral-ventricle
enlargement, neuroinflammation, Aβ deposition, altered
insulin signaling/BBB, hippocampal injury, and impairment
in learning and memory (Amtul and Hepburn, 2014; Amtul
et al., 2011a,b, 2014, 2018a,c; Yang et al., 2014; Amtul, 2016,
2018). Using sequential computed tomography (CT) imaging
we have also established altered microperfusion and associated
elevated BBB disruption in the comorbid model of Aβ toxicity
and ischemia (Yang et al., 2014; Amtul et al., 2018d). Surprisingly
little is known about the effect of comorbid injury on the
anatomical alteration of cerebrovasculature, topographic
distribution, density, diameter and their role in maintaining
cerebral water homeostasis and vessel-matrix-connections. Due
to the serious consequences; damage to cerebral vasculature
homeostasis and thus function must be considered a critical
contributing component in the development of neurological
disorders. Moreover, analyzing the vascular anatomical defects
is also essential for adequate interpretation of brain imaging
data to take us one step closer to develop remedies to restore
vascular architecture, which may emerge as a new therapeutic
target. Therefore, our working hypothesis is that the alteration
in microvascular anatomy, texture, diameter, density, protein
expression, and function serve as the interrelated pathogenic and
etiologic link between AD and ischemia. Therefore, in the present
study, we studied the anatomy of striatal microvasculature and
the associated effects on water exchange and vascular-matrix
connections by investigating various vascular markers at different
time points in a comorbid rat model of Aβ toxicity and ischemia.
MATERIALS AND METHODS
Study Design and Animal Treatment
All of the animal experiments were conducted in full compliance
with the guidelines and approval of the Animal Care and Use
Committee of the Western University (approval ID: 2008-113).
All possible steps were taken to reduce the number of animals
and their discomfort level. Two- to three-month old male Albino
Wistar rats (Charles River Canada) weighing 250 to 310 g
at the beginning of the experiment were used. Animals were
divided into four groups for three different (d1, d7, and d28)
timelines (n = 4 for each group). For stereotactic surgery, the
animals were positioned into David Kopf stereotaxic apparatus
(David Kopf Instruments, Tujunga, CA, United States) and
anesthetized using 1.8% isoflurane. Body temperatures were
maintained at 37◦C throughout the surgery with the help of a
heated blanket. To insert 30 gauge Hamilton needle, three burr
holes were drilled in the parietal bone of each rat. All stereotaxic
coordinates were determined using Paxinos and Watson Atlas
(Paxinos and Watson, 2005).
Induction of Striatal Cerebral Ischemia
The rat model of ischemia (group 1; ET1) receiving 60 pmol/3 µL
injection of endothelin-1 (ET1; Sigma-Aldrich, Oakville, ON,
Canada) into the right striatum (anterior/posterior +0.5 mm,
medial/lateral −3.0 mm relative to bregma, and dorsoventral
−5.0 mm below dura) has been described in detail elsewhere
(Amtul et al., 2014, 2018a,b,c).
Induction of β-Amyloid Toxicity
The rat model of β-amyloid toxicity (group 2; Aβ) receiving
bilateral ICV injections of oligomeric 50 nM Aβ25–35/10 µL was
modeled (anterior/posterior: −0.8 mm, mediolateral: ± 1.4 mm
relative to bregma, and dorsoventral: −4.0 mm below dura) as
described in detail elsewhere (Amtul et al., 2014, 2018a,b,c).
Induction of Comorbidity and Control
Procedure
Third group of rats received both bilateral ICV Aβ25–35 and
unilateral striatal ET1 injections (group 3; Aβ+ET1) as described
(Amtul et al., 2014, 2018a,b,c). The control rats (group 4; Control)
received saline injections in identical locations.
Post-surgery Treatment
After stitching the skin incisions, all rats were administered a
subcutaneous injection of 0.03 mg/kg buprenorphine (Temgesic,
RB Pharmaceuticals Ltd., Berkshire, United Kingdom) and an
intramuscular injection of 1 mg/20 µl enrofloxacin antibiotic
(Baytril, Bayer Inc., Canada). Twenty four hours (d1), 7 days
(d7), and 28 days (d28) following surgery, corresponding rats
were euthanized by an intraperitoneal pentobarbital overdose
(Pentobarbital Sodique, Ceva Santé Animale, Cambridge, ON,
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Canada) followed by a transaortic perfusion with heparin
containing phosphate buffered saline (PBS) and thereafter by 4%
paraformaldehyde (pH 7.4).
Tissue Preparation
The brains were harvested, postfixed in 4% paraformaldehyde,
and cryopreserved in 30% cold (4◦C) sucrose solution for 36 h.
Next, the entire rat brains were serially sliced into 35 µm thick
coronal cryosections.
Immunohistochemistry
Immunoperoxidase protocol of avidin-biotin-peroxidase
complex (ABC) was carried out as described (Hsu et al.,
1981) to stain the free-floating cryosections with the following
antibodies: Matrix metalloproteinase-9 (MMP-9; 1:1000,
Millipore, AB19016), β-dystroglycan (βDG; 1:200, Leica B-DG-
CE-S); βDG is an extracellular matrix adhesion protein abundant
in astrocytic endfeet, co-localized with AQP4 and laminin and
is needed for precise astrocytic anchoring around the cerebral
vasculature (Zaccaria et al., 2001; Milner et al., 2008). SMI71
(Covance, 1:2000), an explicit endothelial barrier antigen (EBA)
restricted to the luminal surfaces of all mature endothelium of
the vasculature with intact BBB. BM-Laminin (1:1000, Sigma,
L 9393) staining was used as an indicator of the BM rupturing,
while neurons also contain laminin like molecules. For astrocytic
antigen, glial fibrillary acidic protein (GFAP, 1:1000, Sigma,
G3893) and binary water-channel protein, aquaporin4 (AQP4,
1:1000, Chemicon, AB2218) were employed. Fluorophore-
conjugated donkey anti-rabbit FITC ( Sc-2090, 1:500) and
donkey anti-mouse TR, (Sc-2785, 1:500) were prepared in 0.3%
Triton X-100 containing 0.1 M PBS were used for fluorescence
staining. Serums, biotinylated antibodies, and ABC reagent
were purchased from the Vectastain Elite ABC Kit (Vector
Laboratories, Inc., Burlingame, CA, United States).
Analyses
Histological sections of brain were analyzed under light and
fluorescence microscope. Leica Digital Camera DC 300 (Leica
Microsystems Ltd., Heerbrugg, Switzerland) connected to a Leitz
Diaplan microscope was used to take the photomicrographs.
Cells and blood vessels were identified and counted, blindly, on
the basis of positive labeling in the region of interest (ROI) on
six non-neighboring slices with 210 µm distance between the
sections using systematic random sampling method.
The Region of Interest Determination
The region of positive laminin staining on consecutive slices in
the right hemisphere (ipsilateral to the striatal ischemia) was
noted as the location of the signal. This signal was limited to the
striatal region between 1.6 to −0.92 mm anterior to posterior,
relative to bregma. All histological analyses were performed
in this region of the sections. The center of the ROI with
dense laminin staining may alternatively be termed as lesion
epicenter or lesion core, while the ROI surrounding the epicenter
is termed as penumbra throughout the study. Six microscopic
fields-of-view (each covering an area of about 0.50 mm2) in the
ROI at 10× to 40× magnification with 0.25 to 0.65 numerical
aperture were analyzed.
Lumen Diameter Measurement
The diameters of lumen were determined using the ImageJ’s
(National Institute of Health, version 1.48, United States)
diameterJ plug-in analysis tool. Pixels in images with known
scale bars were converted into micrometer in Image J. Next,
a line selection was drawn across the structure of interest to
measure the diameters.
Vessel/Cell Density Measurement
For vascular/cellular density both manual as well as cell counter
plugin was used to count the number of stained cells, vessels,
layered vessels, split vessels, vessels with fibrosis and vessels with
greater sizes. The results were presented as the number of vessels
or cells per millimeter square of the ROI. Effect of MMP-9 on
vascular fibrosis was quantified by calculating the ratio of the
MMP-9 expression relative to the number of vessels displaying
the fibrosis and expressed as negative log of n.
AQP4 Polarization Measurement
AQP4 polarization is characterized as its dense, concentrated and
localized expression within the astrocytic endfeet, ensheathing
the BBB interface of cerebral microvessels, related to the
astrocytic soma. Likewise, the loss of localized expression of
AQP4 from perivascular endfeet processes and shifting toward
astrocytic soma and coarse processes is referred to as its
depolarization. AQP4 polarization was measured by counting
the number of vessels expressing the AQP4 at their perivascular
astrocytic BBB interface within each field of view. The relative
values for AQP4 polarization on d7 and d28 were expressed as
a percentage of the AQP4 polarization on d1 by normalizing
it to 100 percent.
Fluid-Filled Spaces Measurement
Fluid-filled spaces in the ROI were determined by drawing them
on the computer screen with the help of image J quantification
plugin analysis tools. The fluid-filled space on each section was
normalized to the corresponding striatal volume, and thereafter
to hemispheric swelling by dividing the contralateral hemisphere
volume to the ipsilateral hemispheric volumes, multiplying by
fluid-filled spaces. The relative area of fluid-filled spaces on d7
and d28 was calculated as the percentage volume of the fluid-filled
spaces on d1 by normalizing it to 100 on d1.
Statistical Analyses
All values were displayed as a mean ± standard error of the
mean (S.E.M.). All measurements were analyzed by using one-
way ANOVA followed by post hoc Dunnett’s tests. Except for
inter-group comparisons at different time points, a t-test was
used, and log values, two-way ANOVA was used. The significance
level was p ≤ 0.05.
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RESULTS
This is the first comprehensive histopathologic study
of blood vessels pathology after the comorbid cerebral
injury. These data suggest that the development of
vascular pathology is a global phenomenon that
affects the vascular dilation, lumen diameter, basement
membrane integrity as well as the fluid homeostasis
across the injured region after comorbid ischemia and
amyloid toxicity.
Dilated Blood Vessels and Lumen
Diameter
In control rats, laminin antibody only detected neurons, and
in Aβ rats a few faint, isolated microvessels at each time
point (Figure 1A). This is consistent with the literature that
shows that in PFA-perfused tissues the laminin antibody
does not stain BM-laminin but only neurons (Hagg et al.,
1989). Conversely, a significantly robust network of capillaries
containing BM-laminin is usually promptly evident after
Aβ+ET1 or ET1 injections in the lesion epicenter due
to the damage to BM and enhanced antibody penetration
resulting in the robust staining of laminin protein. Alongside
an intermittent yet widespread increase in the diameter
of microvessels (square boxes) within the lesion core of
Aβ+ET1 than ET1 rats (p = 0.054) was readily detected
immediately after the injury compared to the control
(p = 0.0005) and Aβ (p = 0.0006) rats (Figures 1B,D).
Numerous thinning out laminin-positive pyknotic neurons
were also obvious in the lesion core of ET1 and Aβ+ET1
rats on d1 (Figure 1B). Dilated microvessels in ET1 and
Aβ+ET1 rats with larger lumen diameter (Figures 1C,E) also
demonstrate punctate SMI71 staining of the luminal surface
of the endothelial cells indicating BBB break down in those
microvessels (Figure 1C).
FIGURE 1 | Dilated blood vessels and lumen diameter: Control and Aβ rats show BM-laminin positive neurons on d1. Aβ rats also show some isolated, inconsistent
laminin stained microvessels (A). Several dilated microvessels and numerous declining typical pyknotic neuronal cells can be seen in the ROI of ET1 and Aβ+ET1 rats
on d1 (B). Fluorescent staining of BM-laminin (green) indicates lumen diameters on d1 in the ROI or lesion core of ipsilateral striatum of ET1 and Aβ+ET1 rats.
Punctate SMI71 staining (red) of endothelial cells can also be seen in the background. (C). The plots show quantitative analyses of laminin-stained microvessels with
equal or greater than 10 µm diameter in the ipsilateral striatum of control, Aβ, ET1, and Aβ+ET1 rats (D), and lumen diameter of dilated microvessels in ET1 and
Aβ+ET1 rats (E) on d1, ∗∗∗p < 0.001.
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Basement Membrane Profile and
Disruption
Basement membrane pathology including splitting, dissolution
and rupturing was more prominent in ET1 rats compared to
layering out tunica intima in Aβ+ET1 rats, that represents an
earlier step to splitting (Figures 2A,B,D,E). On d28, laminin
meshwork with degraded BM can be seen throughout the
lesion core with more pronounced splitting around digested
microvessels in ET1 rats and distinct layering in Aβ+ET1
rats (Figures 2C–E). Additionally, ET1 rats on d7 showed
the splitting of BM-laminin with irregular SMI expression. In
contrast, Aβ+ET1 rats showed layering of BM with relatively
regular BBB (Figure 2B). Images on both fluorescent and
0.05% DAB staining were included to provide readers better
clarity and resolution that might have been missed by the one
procedure or another.
MMP-9 Expression and Microvascular
Fibrosis
In control and Aβ rats, MMP-9 appeared to stain a large
number of neuronal cells, as obvious from their structure and
distribution pattern (Figure 3A). While in ET1 and Aβ+ET1
rats on d1, MMP-9 stained striatal cells that appeared to be
the reminiscent of microvascular endothelium, representing the
disturbed vascular-matrix connection, with more in ET1 and
less in Aβ+ET1 rats (Figure 3B). On d7, in the penumbra-core
interface MMP-9 started appearing as astrocytes (Figure 3C).
On d28 MMP-9 staining showed complete loss of endothelial
profile observed on d1, and strongly indicated an expression
of astrocytes in the lesion core with significantly more in ET1
brains than Aβ+ET1 (p < 0.05) rats (Figure 3D). Besides, the
capillary structure in the lesion core started getting severely
compromised (Figure 3E). The percent fibrosis of vessels in
Aβ+ET1 rats was strongly correlated with an MMP-9 increase
(p = 0.033) in the lesion core, suggesting that fibrosis was
a critical process in the penumbra of Aβ+ET1 rats. The
images themselves contain sufficient detail to clearly display
capillary structures, allowing the visualization of principal
BM layer and the vasculature. More detailed visualization of
capillary atrophy intercalated by a dense BM network included
string, fragmented and tortuous structures (circle). An uneven
thickening on the abluminal surface of capillaries, duplication,
branching (three arrows), and microvascular fibrosis of BM
(dotted line), was common in the lesion core of treated
rats, in general.
FIGURE 2 | Basement membrane profile and disruption: Fluorescent images indicate an increase in BM-laminin immunoreactivity (green) in the lesion core localized
to the ipsilateral striatum of ET1 and Aβ+ET1 rats from d1 (A) to d28 (C). On d7, the BM starts splitting out in ET1 rats and layering out in Aβ+ET1 rats. A punctate
and faint SMI71 staining indicative of disrupted BBB is also observed in microvessels with greater BM-laminin leakage, dissolution, and destabilization (B). On d28,
splitting reaches to its peak in ET1 rats while layering started fading out in Aβ+ET1 rats (C). The plots show quantitative analyses of laminin-stained microvessels
showing layering (D) and splitting (E) in the ipsilateral striatum of ET1 and Aβ+ET1 rats on d1, d7, and d28.
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FIGURE 3 | MMP-9 expression and microvascular fibrosis: DAB staining shows expression pattern of MMP-9 in the lesion core of the ipsilateral striatum of control,
Aβ (A) ET1 and Aβ+ET1 rats from d1 to d28 (B–D). In control and Aβ rats MMP-9 exclusively stain neuronal cells throughout the course of study (A). On d1, MMP-9
is mainly expressed by the neuronal (pyknotic) cells and occasionally by the endothelial cells in the lesion core of ET1 and Aβ+ET1 rats (B). On d7, MMP-9 staining
still shows neuronal profile and appearance of astrocytic morphology (C). On d28, MMP-9 acquires massive astrocytes appearance (D). High-resolution images of
BM-laminin staining show different stages of capillary wall pathology from d1 to d28 in Aβ+ET1 rats, such as stringed and tortuous structures (circle), local irregular
thickening on the abluminal surface of capillaries, duplication, branching (three arrows), and fibrosis of BM (dotted line) (E). The plot shows –log of the ratio of the
MMP-9 expression relative to the number of vessels displaying fibrosis (F) in the ipsilateral striatum of ET1 and Aβ+ET1 rats on d1, d7, and d28.
FIGURE 4 | Aquaporin4 polarization vs. fluid homeostasis: Fluorescent images show the expression pattern of AQP4 immunostaining in the ROI of control, Aβ, ET1,
and Aβ+ET1 rats from d1 to d28 (A–C). The punctate AQP4 expression on d1 in ET1 and Aβ+ET1 rats (A) starting to depolarize on d7 (B) and intensely
depolarized on d28 (C). While control rats show smooth, regular AQP4 staining throughout, and Aβ rats show an increase in AQP4 haziness from d1 to d28 (A–C).
Low-resolution images show the topographical distribution of fluid-filled spaces by astrocytes (D) and βDG (E) immunostaining in the penumbra and lesion core;
ROI of Aβ+ET1 rat on d1 (D) and d28 (E). The epicenter of the lesion core also shows a prominent necrotic lesion (asterisk) (D,E), lv; lateral ventricles.
High-resolution image shows depolarization of AQP4 expression from GFAP positive astrocytic end-feet to the astrocytic soma (F). The plot shows a quantitative
decrease in AQP4 polarization and fluid-filled spaces in an anterior (+) to posterior (−) manner from the bregma (0), in the ipsilateral striatum of ET1 and Aβ+ET1 rats
from d1 to d28 (G).
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AQP4 Polarization vs. Fluid Homeostasis
Within 24 h, AQP4 staining was highly polarized around
endothelial cells of microvessels in control (p = 0.002) and Aβ
(p = 0.001) brains compared to the ET1 and Aβ+ET1 brains. On
the contrary, AQP4 staining appeared punctate in the lesion core
of ET1 and Aβ+ET1 rats. While the neuropil space in between the
AQP4 stained vessels was missing any AQP4 staining in Aβ+ET1
rats, in ET1 rats it exhibited haziness indicative of relocation
of AQP4 protein (Figure 4A). On d7, the depolarization of
AQP4 became more distinct in ET1 and Aβ+ET1 rats and
a hazy fluorescence appeared to extend into the neighboring
neuropil compared to control and Aβ rats (Figure 4B). On d28,
an increased AQP4 immunoreactivity was accompanied by the
re-distribution of polarized AQP4 expression from astrocytic
endfeet to the soma with more in ET1 rats than Aβ+ET1
rats (Figure 4C). A subset of microvessels in Aβ rats showed
AQP4 haziness and depolarization on d28; however, it did
not reach statistical significance (Figure 4C). Low-resolution
images indicated the topographical immunostaining of GFAP
(Figure 4D), and βDG positive (Figure 4E) astrocytes in the
ipsilateral striatum of Aβ+ET1 rat brain on d28. On d1, both
ET1 and Aβ+ET1 rats had approximately a100% increase in
fluid-filled spaces in the ROI compared to control and Aβ rats,
consistent with the vasogenic edema formation (Figures 4D,G).
While, on d28 with the increase in AQP4 depolarization, the
size of these fluid-filled spaces got shrunk to one-third of their
original size from d1 (R = 0.96, p = 0.0001) (Figure 4E). The
dark line showed the division between core and penumbra,
where a palisade layer is formed by GFAP positive astrocytes.
While βDG expression on astrocytic end feet demonstrates an
attempt by the astrocytes to restore vascular-matrix connections
(Figures 4D,E). The high-resolution image showed co-labeling of
AQP4 and GFAP staining to demonstrate AQP4 depolarization
from astrocytic foot processes to soma in the fluid-filled space
in an Aβ+ET1 rat on d28, in an attempt to increase the
inter-compartmental water exchange from fluid-filled spaces to
the bloodstreams (Figure 4F). Co-expressed GFAP and AQP4
staining were not used for any quantitative analyses.
DISCUSSION
In this study, we demonstrate that the comorbid occurrence
of ischemia and Aβ toxicity provoked substantial dynamic,
rapid and highly coordinated changes in the vascular anatomy
and physiology in the striatal lesion core and penumbra of
Aβ+ET1 rats. The present study also showed a correlation
between vascular structure deterioration and the deficits in
microvascular responses, such as inter-compartmental water
exchange and vessel-matrix-connections of cerebral capillaries
after comorbid injury.
Immediately after ET1 and/or Aβ+ET1 injections, the
compression of small capillaries (not arterioles and venules) and
a drop in cerebral perfusion, due to the potent vasoconstrictive
effects of ET1, led to the dilation of precapillary resistance vessels
in order to maintain cerebral perfusion. This was observed by
the homogenous distribution of certain vessels with increased
diameter throughout the penumbra in Aβ+ET1 rats compared to
ET1 rats on d1. This shifted the calculated average size of vessels
to the considerably larger values in Aβ+ET1 rats. Whereas the
changes in the microvessels structure in ET1 rats accompanied
by a decrease in the outer diameters of the vessel lumen. These
alterations perhaps referring to some hyperplasia or hypertrophy
of the vessel wall in these rats, significantly impacted vascular
function (Baumbach and Heistad, 1989). This also referred to a
different pattern of remodeling in Aβ+ET1 rats compared to ET1
rats alone (Figure 1).
Following flow restoration in the constricted vessels, the
downstream capillary network endured the impact (del Zoppo
et al., 2000). For instance, in injured rats once maximum
vasodilation was reached, autoregulation failed and progressive
continued compression of small capillaries (Liebeskind, 2003)
finally resulted in the opening of tight junction proteins of
endothelial cells and breakdown of BBB permeability, as observed
by a punctate EBA or SMI71 staining in ET1 and Aβ+ET1 rats on
d7 (Figure 2B).
A breakdown of BBB or permeability barrier was accompanied
by significant alterations in microvessel structure in these rats.
As, spatially endothelial cells are in a perfect position to sense
minor changes in cerebral perfusion, thus shear stress. These
pathologic changes seemed to first affect the intima, media,
and adventitia layers of microvessels. Immediately after injury,
these layers started separating from the vessels, however, more
robustly in ET1 rats compared to the Aβ+ET1 rats. As, ET1 rats
demonstrated splitting, which is usually followed by a vascular
layering of tunica intima; that comprised of endothelial cells
and the contiguous BM (Stratman et al., 2009), starting from
d7 (Figure 2B). Possibly, our endpoint timing of euthanization
couldn’t catch the window of vascular layering in ET1 rats.
Splitting, in turn, led to multiple tears within the microvascular
layers and BM-endothelium of ET1 rats by d28 (Figure 2C).
This study also highlights vascular fibrosis or vascular BM
thickening as a pathologic phenomenon associated with ischemia
and comorbid injury. In Aβ+ET1 brains, BM sufferd the most
dramatic and pronounced damage and emerged as a central
target of vascular pathological changes (Hawkes et al., 2011;
Figure 3). Vascular fibrosis; linked with many pathological
processes and clinical conditions (Harvey et al., 2016) is
characterized by reduced compliance, such as lumen diameter,
increased vascular collagen, reduced elasticity (Selvin et al., 2010),
and associated excessive deposition/remodeling of extracellular
matrix (ECM) (Iwazu et al., 2011). Increased expression and
activation of matrix metalloproteinases (MMP) is characterized
as one of the molecular mechanisms underlying ECM remodeling
and vascular fibrosis (Epstein et al., 1994). Accordingly, many
of the partially digested microvessels that still remained in
the striatal lesion core were associated with MMP-9 positive
staining in ET1 and Aβ+ET1 rats on d1 (Figure 3B) indicating
the diminishing or residual vessel-matrix-connections. By d28
complex interplay between ischemia, Aβ toxicity and astrocytic
expression of MMP-9 (Zhao et al., 2006; Wang and Hatton,
2009; Figure 3D), resulted in accelerated vascular remodeling
(as observed by elevated astrocytic expression) in ET1 rats and
fibrosis (as accompanied by lowered astrocytic expression) in
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Aβ+ET1 rats. This again confirms a different pattern of
remodeling in ET1 and Aβ+ET1 rats, as mentioned above.
In addition, the presence of cerebral microvessels with string,
tortuous structures (Figure 3E) and reduced capillary density in
Aβ+ET1 rats may be responsible for the increased resistance of
microvessels and resulting moderate hemodynamic obstruction
in these rats by d28, reported earlier (Yang et al., 2014).
The very peculiar set of idiosyncratic variations was noticed
in the polarized expression of end feet pool of AQP4 from
d1 to d28 (Figure 4). Within 24 h, punctate, granulated,
polarized expression of AQP4 channel protein, enclosing the
cerebral endothelial layers in the lesion core demonstrated re-
localization or redistribution from the end feet membranes
to the parenchymal soma membranes of the astrocyte body
starting from d7 (Wolburg-Buchholz et al., 2009). Perhaps this
is to aid in astroglial migration toward fluid-filled spaces in
forming glial scar in the lesion core, necessary for filopodia
formation (Saadoun, 2005; Badaut et al., 2007), as well as to
help in intra-astroglial water accumulation or cytotoxic edema
in an effort to clear up fluid-filled spaces formed in the lesion
core of ET1 and Aβ+ET1 rats on d1 (Figures 4D,E). On d28,
the reduction in fluid-filled spaces in injured rats when AQP4
depolarization was at its peak, confirmed its role as the principle
bidirectional water transporting channel of astrocytes (Nagelhus
et al., 2004) and thus in fluid clearance from the brain into
the bloodstream.
Currently, it is uncertain if Aβ rats will express significant
degeneration in vascular physiology and markers in a four-
week time frame, as Aβ toxicity alone was not detrimental
enough. Low numbers of animals per group (n = 4) might
be a contributing limiting factor. However, in the given time,
striatal microvessels in the Aβ rats showed vascular degeneration
and BBB disruption compared with controls, although non-
significantly. Further studies with extended time intervals will
likely provide an enhanced appreciation of the structural links of
vascular injury with vascular responses in these rats.
In summary, we propose that the anatomical or morphological
alterations in the cerebral network of microvessels after injury
could be used effectively to describe the neuropathology of the
injured brain. For example, the impaired BBB restoration after
Aβ+ET1 toxicity reported earlier (Amtul et al., 2018d) might be
the direct cause of the altered anatomy of the cerebral vasculature
in these rats. Lastly, longitudinal magnetic resonance evaluations
can aid to correlate imaging of vessel size and microvascular
morphology to the fate of neural tissue to further improve the
tailoring of the treatments. Such an investigation could lead
to a new rationale to induce vascular remodeling by designing
therapeutics for demented patients.
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